We are live on
!
Find out more
SCA
Spearhead Capital Advisors Portfolio holdings
AUM
$92.3M
1-Year Est. Return
18.16%
This Fund
S&P 500
This Quarter
Est. Return
-5.97%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
–
AUM
$808M
AUM Growth
-$20.8M
(-2.5%)
Cap. Flow
+$35.8M
Cap. Flow
% of AUM
4.43%
Top 10 Holdings %
Top 10 Hldgs %
31.44%
Holding
237
New
60
Increased
70
Reduced
61
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coinbase
COIN
|
+$9.46M |
| 2 |
Walt Disney
DIS
|
+$7.58M |
| 3 |
Adobe
ADBE
|
+$5.32M |
| 4 |
Salesforce
CRM
|
+$5.02M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$4.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$11.3M |
| 2 |
Clorox
CLX
|
+$9.51M |
| 3 |
3M
MMM
|
+$9.01M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.11M |
| 5 |
Vanguard Consumer Discretionary ETF
VCR
|
+$2.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.68% |
| 2 | Healthcare | 12.5% |
| 3 | Financials | 10.48% |
| 4 | Consumer Staples | 9.36% |
| 5 | Consumer Discretionary | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
101
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $397K | 0.05% |
+6,483
| New | +$337K |
|
102
Berkshire Hathaway Class B
BRK.B
$1.1T
| $395K | 0.05% |
+1,119
| New | +$362K |
|
103
Tenable Holdings
TENB
$3.6B
| $393K | 0.05% |
6,808
-3,997
| -37% | -$206K |
|
104
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $392K | 0.05% |
+7,051
| New | +$407K |
|
105
Moderna
MRNA
$21.8B
| $392K | 0.05% |
2,275
+744
| +49% | +$125K |
|
106
CarGurus
CARG
$3.27B
| $372K | 0.05% |
+8,755
| New | +$322K |
|
107
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
| $372K | 0.05% |
+6,390
| New | +$379K |
|
108
Fortinet
FTNT
$119B
| $368K | 0.05% |
+5,380
| New | +$334K |
|
109
Riot Platforms
RIOT
$7.63B
| $367K | 0.05% |
+17,320
| New | +$313K |
|
110
Chegg
CHGG
$110M
| $361K | 0.04% |
+9,957
| New | +$300K |
|
111
CrowdStrike
CRWD
$194B
| $360K | 0.04% |
6,336
-1,948
| -24% | -$90.8K |
|
112
Alnylam Pharmaceuticals
ALNY
$27.5B
| $355K | 0.04% |
2,177
-905
| -29% | -$138K |
|
113
Exelixis
EXEL
$13.3B
| $355K | 0.04% |
+15,669
| New | +$306K |
|
114
Datadog
DDOG
$95.4B
| $352K | 0.04% |
+2,321
| New | +$340K |
|
|
SWAV
115
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $348K | 0.04% |
+1,677
| New | +$276K |
|
116
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $342K | 0.04% |
5,764
+100
| +2% | +$6.01K |
|
117
Cloudflare
NET
$99B
| $338K | 0.04% |
2,821
-2,885
| -51% | -$301K |
|
118
Castle Biosciences
CSTL
$855M
| $334K | 0.04% |
+7,437
| New | +$307K |
|
119
Freshpet
FRPT
$2.93B
| $334K | 0.04% |
3,250
+353
| +12% | +$33.2K |
|
120
Fidelity MSCI Industrials Index ETF
FIDU
$2.3B
| $333K | 0.04% |
+6,184
| New | +$329K |
|
121
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $328K | 0.04% |
4,203
-12
| -0.3% | -$954 |
|
|
AXNX
122
DELISTED
Axonics, Inc. Common Stock
AXNX
| $326K | 0.04% |
+5,204
| New | +$280K |
|
123
PagerDuty
PD
$816M
| $325K | 0.04% |
+9,497
| New | +$305K |
|
124
Inspire Medical Systems
INSP
$1.45B
| $322K | 0.04% |
1,254
-824
| -40% | -$188K |
|
125
DexCom
DXCM
$31.5B
| $316K | 0.04% |
2,472
-2,116
| -46% | -$231K |
|
Similar funds
AAM
AEPBI
MW
SC
NIM
WIM
LAM
EFEM
Spearhead Capital Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Spearhead Capital Advisors held 237 positions worth $808M, down 2.5% from $828M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Spearhead Capital Advisors deployed $35.8M of net new capital in Q1 2022, opening 60 new positions and adding to 70 existing holdings. Its largest new stake was Coinbase: 48,405 shares worth $9.19M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Consumer Discretionary ETF, an estimated $2.95M trimmed.
- Spearhead Capital Advisors's largest Q1 2022 buy was Coinbase: 48,405 shares worth $9.19M.
- Spearhead Capital Advisors added most to Walt Disney in Q1 2022, an estimated $7.58M increase.
- Spearhead Capital Advisors's biggest Q1 2022 reduction was Vanguard Consumer Discretionary ETF, cutting an estimated $2.95M.
- Spearhead Capital Advisors fully exited Bank of America in Q1 2022, selling an estimated $11.3M.
- Spearhead Capital Advisors's ten largest holdings make up 31% of its $808M portfolio in Q1 2022.
- Spearhead Capital Advisors opened 60 new positions and closed 44 in Q1 2022.
- Spearhead Capital Advisors's portfolio value fell 2.5% quarter-over-quarter to $808M.
Based on Spearhead Capital Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.